New drug CDX-622 put to the test in healthy people
NCT ID NCT06650761
First seen Nov 01, 2025 · Last updated May 04, 2026 · Updated 22 times
Summary
This early-stage study tested the safety of a new drug called CDX-622 in 85 healthy adults aged 18 to 55. Participants received either the drug or a placebo, and researchers monitored for side effects, drug levels in the blood, and changes in certain body chemicals. The goal was to see if CDX-622 is safe enough to study further in people with medical conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion, Inc.
Tempe, Arizona, 85283, United States
Conditions
Explore the condition pages connected to this study.